Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › NIPT Reimbursement Decision in Germany for High-Risk Pregnancies to Come in 2019

NIPT Reimbursement Decision in Germany for High-Risk Pregnancies to Come in 2019

Feb 21, 2017
|
staff reporter

NEW YORK (360Dx) – German authorities plan to decide in August 2019 about reimbursement by the country’s statutory health insurance system for noninvasive prenatal diagnostic testing for fetal trisomy risk, according to an update announced on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Cleveland Clinic, Three Other Labs Get FDA EUAs for Coronavirus Tests

  2. Roche Epstein-Barr Virus Quantitative Test Receives FDA Clearance

  3. Siemens Gets First Authorizations for Tests That Estimate Quantities of SARS-CoV-2 Antibodies

  4. FDA Grants Emergency Use Authorizations for Zeesan Biotech, UCSD Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.